• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿昔洛韦漂浮药物递送系统的设计与优化

Design and optimization of floating drug delivery system of acyclovir.

作者信息

Kharia A A, Hiremath S N, Singhai A K, Omray L K, Jain S K

机构信息

Oriental College of Pharmacy, Raisen Road, Bhopal-462 021, India.

出版信息

Indian J Pharm Sci. 2010 Sep;72(5):599-606. doi: 10.4103/0250-474X.78527.

DOI:10.4103/0250-474X.78527
PMID:21694992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3116305/
Abstract

The purpose of the present work was to design and optimize floating drug delivery systems of acyclovir using psyllium husk and hydroxypropylmethylcellulose K4M as the polymers and sodium bicarbonate as a gas generating agent. The tablets were prepared by wet granulation method. A 3(2) full factorial design was used for optimization of drug release profile. The amount of psyllium husk (X1) and hydroxypropylmethylcellulose K4M (X2) were selected as independent variables. The times required for 50% (t(50%)) and 70% (t(70%)) drug dissolution were selected as dependent variables. All the designed nine batches of formulations were evaluated for hardness, friability, weight variation, drug content uniformity, swelling index, in vitro buoyancy, and in vitro drug release profile. All formulations had floating lag time below 3 min and constantly floated on dissolution medium for more than 24 h. Validity of the developed polynomial equation was verified by designing two check point formulations (C1 and C2). The closeness of predicted and observed values for t(50%) and t(70%) indicates validity of derived equations for the dependent variables. These studies indicated that the proper balance between psyllium husk and hydroxypropylmethylcellulose K4M can produce a drug dissolution profile similar to the predicted dissolution profile. The optimized formulations followed Higuchi's kinetics while the drug release mechanism was found to be anomalous type, controlled by diffusion through the swollen matrix.

摘要

本研究的目的是设计并优化阿昔洛韦的胃漂浮型给药系统,使用车前子壳和羟丙基甲基纤维素K4M作为聚合物,碳酸氢钠作为产气剂。片剂采用湿法制粒工艺制备。采用3(2)全因子设计优化药物释放曲线。选择车前子壳(X1)和羟丙基甲基纤维素K4M(X2)的用量作为自变量。选择药物溶解50%(t(50%))和70%(t(70%))所需的时间作为因变量。对设计的9批制剂进行硬度、脆碎度、重量差异、药物含量均匀度、溶胀指数、体外漂浮性和体外药物释放曲线评价。所有制剂的漂浮滞后时间均低于3分钟,并在溶出介质中持续漂浮超过24小时。通过设计两个验证点制剂(C1和C2)验证了所建立多项式方程的有效性。t(50%)和t(70%)预测值与实测值的接近程度表明所推导方程对因变量的有效性。这些研究表明,车前子壳和羟丙基甲基纤维素K4M之间的适当平衡可以产生与预测溶出曲线相似的药物溶出曲线。优化后的制剂符合Higuchi动力学,药物释放机制为非Fick扩散,受通过溶胀基质的扩散控制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0781/3116305/cc986fafced5/IJPhS-72-599-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0781/3116305/9158b5b38908/IJPhS-72-599-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0781/3116305/ee5656ca8a05/IJPhS-72-599-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0781/3116305/03e35da6420a/IJPhS-72-599-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0781/3116305/ad41dcc8ba1c/IJPhS-72-599-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0781/3116305/65cd05026d1c/IJPhS-72-599-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0781/3116305/cc986fafced5/IJPhS-72-599-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0781/3116305/9158b5b38908/IJPhS-72-599-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0781/3116305/ee5656ca8a05/IJPhS-72-599-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0781/3116305/03e35da6420a/IJPhS-72-599-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0781/3116305/ad41dcc8ba1c/IJPhS-72-599-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0781/3116305/65cd05026d1c/IJPhS-72-599-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0781/3116305/cc986fafced5/IJPhS-72-599-g012.jpg

相似文献

1
Design and optimization of floating drug delivery system of acyclovir.阿昔洛韦漂浮药物递送系统的设计与优化
Indian J Pharm Sci. 2010 Sep;72(5):599-606. doi: 10.4103/0250-474X.78527.
2
Formulation and evaluation of mixed matrix gastro-retentive drug delivery for famotidine.法莫替丁混合基质胃滞留型药物递送系统的制剂与评价
Int J Pharm Investig. 2011 Oct;1(4):247-54. doi: 10.4103/2230-973X.93006.
3
Optimization of acyclovir oral tablets based on gastroretention technology: factorial design analysis and physicochemical characterization studies.基于胃滞留技术的阿昔洛韦口服片剂的优化:析因设计分析和理化特性研究。
Drug Dev Ind Pharm. 2011 Jul;37(7):855-67. doi: 10.3109/03639045.2010.546404. Epub 2011 Mar 14.
4
Formulation and evaluation of gastro-retentive floating bilayer tablet for the treatment of hypertension.用于治疗高血压的胃滞留漂浮双层片的制剂与评价
Heliyon. 2020 Nov 13;6(11):e05459. doi: 10.1016/j.heliyon.2020.e05459. eCollection 2020 Nov.
5
Formulation and evaluation of floating tablets of liquorice extract.甘草提取物漂浮片的制剂与评价
Pharmacognosy Res. 2010 Sep;2(5):304-8. doi: 10.4103/0974-8490.72329.
6
Development and in vitro evaluation of an oral floating matrix tablet formulation of diltiazem hydrochloride.盐酸地尔硫䓬口腔漂浮型骨架片制剂的研制与体外评价
AAPS PharmSciTech. 2007 Sep 7;8(3):E73. doi: 10.1208/pt0803073.
7
Statistical Design and Optimization of Sustained Release Formulations of Pravastatin.普伐他汀缓释制剂的统计设计与优化
Turk J Pharm Sci. 2020 Apr;17(2):221-227. doi: 10.4274/tjps.galenos.2019.70048. Epub 2020 Apr 24.
8
Intragastric floating drug delivery system of cefuroxime axetil: In vitro evaluation.头孢呋辛酯胃内漂浮给药系统:体外评价
AAPS PharmSciTech. 2006 Mar;7(1):E118-E124. doi: 10.1208/pt070117. Epub 2017 Mar 8.
9
Formulation and evaluation of floating matrix tablet of stavudine.司他夫定胃漂浮型骨架片的研制与评价
Int J Pharm Investig. 2012 Apr;2(2):83-9. doi: 10.4103/2230-973X.100047.
10
Comparative evaluation of single and bilayered lamotrigine floating tablets.单双层拉莫三嗪漂浮片的比较评价
Int J Pharm Investig. 2013 Jul;3(3):157-62. doi: 10.4103/2230-973X.119227.

引用本文的文献

1
Statistical Design and Optimization of Sustained Release Formulations of Pravastatin.普伐他汀缓释制剂的统计设计与优化
Turk J Pharm Sci. 2020 Apr;17(2):221-227. doi: 10.4274/tjps.galenos.2019.70048. Epub 2020 Apr 24.
2
Development of a gastroretentive delivery system for acyclovir by 3D printing technology and its in vivo pharmacokinetic evaluation in Beagle dogs.利用 3D 打印技术开发阿昔洛韦胃滞留递药系统及其在比格犬体内的药代动力学评价。
PLoS One. 2019 May 15;14(5):e0216875. doi: 10.1371/journal.pone.0216875. eCollection 2019.
3
Preparation and - evaluation of acyclovir floating tablets.

本文引用的文献

1
Studies on formulation and in vitro evaluation of floating matrix tablets of domperidone.多潘立酮胃内漂浮片的处方及体外评价研究
Indian J Pharm Sci. 2009 Jan;71(1):19-23. doi: 10.4103/0250-474X.51944.
2
Evaluation of porous carrier-based floating orlistat microspheres for gastric delivery.基于多孔载体的漂浮型奥利司他微球用于胃内给药的评价。
AAPS PharmSciTech. 2006 Nov 10;7(4):90. doi: 10.1208/pt070490.
3
Intragastric floating drug delivery system of cefuroxime axetil: in vitro evaluation.头孢呋辛酯胃内漂浮给药系统:体外评价
阿昔洛韦胃漂浮片的制备与评价
Res Pharm Sci. 2017 Apr;12(2):128-136. doi: 10.4103/1735-5362.202451.
4
QbD-Enabled Development of Novel Stimuli-Responsive Gastroretentive Systems of Acyclovir for Improved Patient Compliance and Biopharmaceutical Performance.基于质量源于设计(QbD)理念开发新型阿昔洛韦刺激响应性胃滞留系统,以提高患者顺应性和生物药剂学性能。
AAPS PharmSciTech. 2016 Apr;17(2):454-65. doi: 10.1208/s12249-015-0367-0. Epub 2015 Aug 4.
5
Role of excipients and polymeric advancements in preparation of floating drug delivery systems.辅料及聚合物进展在漂浮药物递送系统制备中的作用
Int J Pharm Investig. 2015 Jan-Mar;5(1):1-12. doi: 10.4103/2230-973X.147219.
6
Preparation and evaluation of berberine alginate beads for stomach-specific delivery.制备并评价小檗碱海藻酸钠微球用于胃部的靶向给药。
Molecules. 2011 Dec 14;16(12):10347-56. doi: 10.3390/molecules161210347.
AAPS PharmSciTech. 2006 Feb 24;7(1):E17. doi: 10.1208/pt070117.
4
Floating drug delivery systems: a review.漂浮药物递送系统:综述
AAPS PharmSciTech. 2005 Oct 19;6(3):E372-90. doi: 10.1208/pt060347.
5
Development of sustained release gastroretentive drug delivery system for ofloxacin: in vitro and in vivo evaluation.氧氟沙星缓释胃滞留给药系统的研制:体外和体内评价
Int J Pharm. 2005 Nov 4;304(1-2):178-84. doi: 10.1016/j.ijpharm.2005.08.009. Epub 2005 Sep 29.
6
Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: preparation and in vitro characterization.用于胃滞留漂浮给药的瑞格列奈硅酸钙基微球:制备与体外表征
J Control Release. 2005 Oct 3;107(2):300-9. doi: 10.1016/j.jconrel.2005.06.007.
7
Gastroretentive drug delivery system of ranitidine hydrochloride: formulation and in vitro evaluation.盐酸雷尼替丁胃滞留给药系统:制剂与体外评价
AAPS PharmSciTech. 2004 Apr 8;5(2):e34. doi: 10.1208/pt050234.
8
Statistical optimization of gastric floating system for oral controlled delivery of calcium.用于口服钙控释的胃漂浮系统的统计优化
AAPS PharmSciTech. 2001 Jan 13;2(1):E1. doi: 10.1208/pt020101.
9
MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES.缓释药物的作用机制。分散于固体基质中的固体药物释放速率的理论分析。
J Pharm Sci. 1963 Dec;52:1145-9. doi: 10.1002/jps.2600521210.
10
Acyclovir serum concentrations following peroral administration of magnetic depot tablets and the influence of extracorporal magnets to control gastrointestinal transit.
Eur J Pharm Biopharm. 1998 Nov;46(3):285-91. doi: 10.1016/s0939-6411(98)00052-6.